These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34736124)

  • 1. King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis.
    Introna A; Milella G; Morea A; Ucci M; Fraddosio A; Zoccolella S; D'Errico E; Simone IL
    J Neurol Sci; 2021 Dec; 431():120041. PubMed ID: 34736124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the ability of the King's and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis.
    Luna J; Couratier P; Lahmadi S; Lautrette G; Fontana A; Tortelli R; Logroscino G; Preux PM; Copetti M; Benoit M
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):478-485. PubMed ID: 33829938
    [No Abstract]   [Full Text] [Related]  

  • 3. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.
    Thakore NJ; Lapin BR; Kinzy TG; Pioro EP
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):483-494. PubMed ID: 30001159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
    Gebrehiwet P; Meng L; Rudnicki SA; Sarocco P; Wei J; Wolff AA; Chiò A; Andrews JA; Genge A; Jackson CE; Lechtzin N; Miller TM; Shefner JM
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):304-310. PubMed ID: 36503310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging model for amyotrophic lateral sclerosis in Singapore.
    Tay YT; H Chai JY; Shekh Jabin KB; Ang K
    Singapore Med J; 2022 Jul; 63(7):371-375. PubMed ID: 33472335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts.
    Balendra R; Jones AR; Al Khleifat A; Chiwera T; Wicks P; Young CA; Shaw PJ; Turner MR; Leigh PN; Al-Chalabi A
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):71-81. PubMed ID: 35852375
    [No Abstract]   [Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study.
    Ferraro D; Consonni D; Fini N; Fasano A; Del Giovane C; ; Mandrioli J
    Eur J Neurol; 2016 Sep; 23(9):1426-32. PubMed ID: 27238551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intuitive Staging Correlates With King's Clinical Stage.
    Al Khleifat A; Balendra R; Fang T; Al-Chalabi A
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):336-340. PubMed ID: 33821690
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19.
    Al-Chalabi A; Chiò A; Merrill C; Oster G; Bornheimer R; Agnese W; Apple S
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):165-171. PubMed ID: 33109706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.
    Lunetta C; Lizio A; Melazzini MG; Maestri E; Sansone VA
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):93-100. PubMed ID: 26470943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging amyotrophic lateral sclerosis: A new focus on progression.
    Corcia P; Beltran S; Lautrette G; Bakkouche S; Couratier P
    Rev Neurol (Paris); 2019 May; 175(5):277-282. PubMed ID: 30606512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.
    Fang T; Al Khleifat A; Meurgey JH; Jones A; Leigh PN; Bensimon G; Al-Chalabi A
    Lancet Neurol; 2018 May; 17(5):416-422. PubMed ID: 29525492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.
    Martin S; Trevor-Jones E; Khan S; Shaw K; Marchment D; Kulka A; Ellis CE; Burman R; Turner MR; Carroll L; Mursaleen L; Leigh PN; Shaw CE; Pearce N; Stahl D; Al-Chalabi A
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):569-575. PubMed ID: 28719997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological indices in amyotrophic lateral sclerosis correlate with functional outcome measures, staging and disease progression.
    Barp A; Lizio A; Gerardi F; Tarlarini C; Mauro L; Sansone VA; Lunetta C
    Clin Neurophysiol; 2021 Jul; 132(7):1564-1571. PubMed ID: 34023632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database.
    Paganoni S; Nicholson K; Chan J; Shui A; Schoenfeld D; Sherman A; Berry J; Cudkowicz M; Atassi N;
    Muscle Nerve; 2018 Mar; 57(3):430-434. PubMed ID: 28857199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis.
    Colombo E; Doretti A; Scheveger F; Maranzano A; Pata G; Gagliardi D; Meneri M; Messina S; Verde F; Morelli C; Corti S; Maderna L; Silani V; Ticozzi N
    J Neurol; 2023 Jan; 270(1):511-518. PubMed ID: 36183286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
    Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
    Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting dysphagia onset in patients with ALS: the ALS dysphagia risk score.
    Perry BJ; Nelson J; Wong JB; Kent DM;
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):271-278. PubMed ID: 34375156
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis.
    He J; Fu J; Zhao W; Ren C; Liu P; Chen L; Li D; Tang L; Zhou L; Zhang Y; Ma X; Zhang G; Li N; Fan D
    J Neurol; 2022 Mar; 269(3):1447-1455. PubMed ID: 34274994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.